ADAMTS proteases and cancer

被引:110
作者
Cal, Santiago [1 ]
Lopez-Otin, Carlos [1 ]
机构
[1] Univ Oviedo, Dept Bioquim & Biol Mol, IUOPA, E-33006 Oviedo, Asturias, Spain
关键词
Disintegrin; Metalloprotease; Thrombospondin; Tumorigenesis; Tumor microenvironment; BREAST-CANCER; MATRIX METALLOPROTEINASES; PROTEOLYTIC CLEAVAGE; TUMOR-SUPPRESSOR; EXPRESSION; FAMILY; METHYLATION; DISINTEGRIN; CLONING; GROWTH;
D O I
10.1016/j.matbio.2015.01.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ADAMTSs (A disintegrin and metalloprotease domains with thrombospondins motifs) are complex extracellular proteases that have been related to both oncogenic and tumor-protective functions. These enzymes can be secreted by cancer and stromal cells and may contribute to modify the tumor microenvironment by multiple mechanisms. Thus, ADAMTSs can cleave or interact with a wide range of extracellular matrix components or regulatory factors, and therefore affect cell adhesion, migration, proliferation and angiogenesis. The balance of protumor versus antitumor effects of ADAMTSs may depend on the nature of their substrates or interacting-partners upon secretion from the cell. Moreover, different ADAMTS genes have been found overexpressed, mutated or epigenetically silenced in tumors from different origins, suggesting the direct impact of these metalloproteases in cancer development. However, despite the important advances on the tumor biology of ADAMTSs in recent years, more mechanistic and functional studies are necessary to fully understand how these proteases can influence tumor microenvironment to potentiate cancer growth or to induce tumor regression. This review outlines current and emerging connections between ADAMTSs and cancer. (C) 2015 Published by Elsevier BM.
引用
收藏
页码:77 / 85
页数:9
相关论文
共 73 条
  • [21] Interaction between the ADAMTS-12 metalloprotease and fibulin-2 induces tumor-suppressive effects in breast cancer cells
    Fontanil, Tania
    Rua, Susana
    Llamazares, Maria
    Moncada-Pazos, Angela
    Quiros, Pedro M.
    Garcia-Suarez, Olivia
    Vega, Jose A.
    Sasaki, Takako
    Mohamedi, Yamina
    Esteban, Manuel M.
    Obaya, Alvaro J.
    Cal, Santiago
    [J]. ONCOTARGET, 2014, 5 (05) : 1253 - 1264
  • [22] Decreased expression of ADAMTS-1 in human breast tumors stimulates migration and invasion
    Freitas, Vanessa M.
    do Amaral, Jonatas Bussador
    Silva, Thaiomara A.
    Santos, Emerson S.
    Mangone, Flavia R.
    Pinheiro, Joao de Jesus
    Jaeger, Ruy G.
    Nagai, Maria A.
    Machado-Santelli, Glaucia Maria
    [J]. MOLECULAR CANCER, 2013, 12
  • [23] Fibulins and cancer: friend or foe?
    Gallagher, WM
    Currid, CA
    Whelan, LC
    [J]. TRENDS IN MOLECULAR MEDICINE, 2005, 11 (07) : 336 - 340
  • [24] Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas
    Held-Feindt, J
    Paredes, EB
    Blömer, U
    Seidenbecher, C
    Stark, AM
    Mehdorn, HM
    Mentlein, R
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (01) : 55 - 61
  • [25] The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motility
    Hu, Bin
    Kong, Leopold L.
    Matthews, Russell T.
    Viapiano, Mariano S.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (36) : 24848 - 24859
  • [26] ADAMTS1 inhibits lymphangiogenesis by attenuating phosphorylation of the lymphatic endothelial cell-specific VEGF receptor
    Inagaki, Junko
    Takahashi, Katsuyuki
    Ogawa, Hiroko
    Asano, Keiichi
    Hatipoglu, Omer Faruk
    Cilek, Mehmet Zeynel
    Obika, Masanari
    Ohtsuki, Takashi
    Hofmann, Matthias
    Kusachi, Shozo
    Ninomiya, Yoshifumi
    Hirohata, Satoshi
    [J]. EXPERIMENTAL CELL RESEARCH, 2014, 323 (02) : 263 - 275
  • [27] ADAMTS1: A matrix metalloprotease with angioinhibitory properties
    Iruela-Arispe, ML
    Carpizo, D
    Luque, A
    [J]. TISSUE REMODELING, 2003, 995 : 183 - 190
  • [28] Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas
    Jin, H.
    Wang, X.
    Ying, J.
    Wong, A. H. Y.
    Li, H.
    Lee, K. Y.
    Srivastava, G.
    Chan, A. T. C.
    Yeo, W.
    Ma, B. B. Y.
    Putti, T. C.
    Lung, M. L.
    Shen, Z-Y
    Xu, L-Y
    Langford, C.
    Tao, Q.
    [J]. ONCOGENE, 2007, 26 (53) : 7490 - 7498
  • [29] Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
    Jones, Sian
    Zhang, Xiaosong
    Parsons, D. Williams
    Lin, Jimmy Cheng-Ho
    Leary, Rebecca J.
    Angenendt, Philipp
    Mankoo, Parminder
    Carter, Hannah
    Kamiyama, Hirohiko
    Jimeno, Antonio
    Hong, Seung-Mo
    Fu, Baojin
    Lin, Ming-Tseh
    Calhoun, Eric S.
    Kamiyama, Mihoko
    Walter, Kimberly
    Nikolskaya, Tatiana
    Nikolsky, Yuri
    Hartigan, James
    Smith, Douglas R.
    Hidalgo, Manuel
    Leach, Steven D.
    Klein, Alison P.
    Jaffee, Elizabeth M.
    Goggins, Michael
    Maitra, Anirban
    Iacobuzio-Donahue, Christine
    Eshleman, James R.
    Kern, Scott E.
    Hruban, Ralph H.
    Karchin, Rachel
    Papadopoulos, Nickolas
    Parmigiani, Giovanni
    Vogelstein, Bert
    Velculescu, Victor E.
    Kinzler, Kenneth W.
    [J]. SCIENCE, 2008, 321 (5897) : 1801 - 1806
  • [30] Metalloproteinase-dependent and -independent processes contribute to inhibition of breast cancer cell migration, angiogenesis and liver metastasis by a disintegrin and metalloproteinase with thrombospondin motifs-15
    Kelwick, Richard
    Wagstaff, Laura
    Decock, Julie
    Roghi, Christian
    Cooley, Lindsay S.
    Robinson, Stephen D.
    Arnold, Hugh
    Gavrilovic, Jelena
    Jaworski, Diane M.
    Yamamoto, Kazuhiro
    Nagase, Hideaki
    Seubert, Bastian
    Krueger, Achim
    Edwards, Dylan R.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (04) : E14 - E26